These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12133300)

  • 1. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
    Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
    Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active immunotherapy with anti-idiotypic antibody for patients with nasopharyngeal carcinoma (NPC).
    Li G; Xie L; Zhou G; Zhu J; Hu J; Sun Q
    Cancer Biother Radiopharm; 2002 Dec; 17(6):673-9. PubMed ID: 12537671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
    Li G; Hu J; Zhou G; Zhu J; Sun Q
    Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction and screening of human anti-idiotypic single chain antibodies of nasopharyngeal carcinoma].
    He XJ; Li GC; Zhu JG; Li YH; Zhou GH
    Ai Zheng; 2004 Feb; 23(2):124-9. PubMed ID: 14960228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of monoclonal anti-idiotype antibody that bears the internal image of nasopharyngeal carcinoma associated antigen].
    Li GC; Zhou GH; Zhu JG; Sun QB
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):319-22. PubMed ID: 12205988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
    Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
    Ullenhag GJ; Spendlove I; Watson NF; Indar AA; Dube M; Robins RA; Maxwell-Armstrong C; Scholefield JH; Durrant LG
    Clin Cancer Res; 2006 Dec; 12(24):7389-96. PubMed ID: 17121873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
    Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
    Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma.
    Chow KC; Chiou SH; Ho SP; Tsai MH; Chen CL; Wang LS; Chi KH
    Oncol Rep; 2003; 10(4):813-9. PubMed ID: 12792728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of human bispecific anti-idiotype antibody to elicit humoral and cellular immune responses in mice.
    Wang JJ; Li YH; Liu YH; Song J; Guo FJ; Li YL; Li GC
    Int Immunopharmacol; 2010 Jun; 10(6):707-12. PubMed ID: 20382274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
    Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
    In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
    Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
    Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influences of active immunotherapy on T helper cell type 1 and 2 cytokines in women with unexplained habitual abortion].
    Dong RY; Kong BH; Xu YX; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):362-5. PubMed ID: 12895381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and selection of human anti-idiotypic antibody single chain variable fragments or CDR3 fragments of nasopharyngeal carcinoma.
    He X; Li G; Zhu J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):607-15. PubMed ID: 15743031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001.
    Wagner U; Köhler S; Reinartz S; Giffels P; Huober J; Renke K; Schlebusch H; Biersack HJ; Möbus V; Kreienberg R; Bauknecht T; Krebs D; Wallwiener D
    Clin Cancer Res; 2001 May; 7(5):1154-62. PubMed ID: 11350879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
    Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.